Roche SMA drug shines in study as costly new therapies advance
ZURICH (Reuters) – A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for...
Read More